Rite Aid shares fell in dramatic fashion on Friday.
New bowel drug Trulance will be available for patients later this quarter.
The autoinjector will be free for insured patients and those whose annual income is less than $100,000.
Here's how biotech and healthcare stocks are moving ahead of market's open.
Regulators say company squelched competing drug for infant seizures.
Nominee to oversee health coverage revamp says reform for the individual market should be in place by March
CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.
The pharmaceutical company's new strategy emphasizes new product launches and international expansion.